BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers. This segment also involved in manufacture of close-tolerance and equipment for nuclear applications; down blend government stockpiles of uranium; receives, stores, characterizes, dissolves, recovers, and purifies uranium-bearing materials; and supplies research reactor fuel elements for colleges, universities, and national laboratories, as well as components for defense applications. The Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, and reactor components; and other auxiliary equipment, including containers for the storage of nuclear fuel and other high-level nuclear waste. This segment also offers nuclear fuel, fuel handling systems, tooling delivery systems, nuclear grade materials, and precisely machined components, and related services for CANDU nuclear power plants; provides in-plant inspection, maintenance, and modification services, as well as non-destructive examination and tooling/repair solutions; and manufactures medical radioisotopes, radiopharmaceuticals, and medical devices. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.
Nuclear Niche Leade | BWX Technologies dominates specialized nuclear technology segments, particularly for U.S. Navy contracts, securing a unique market position with high entry barriers |
Financial Forecast | Analysts project EPS of $3.20 for FY2024 and $3.50 for FY2025, with an average price target of $100, reflecting moderate growth expectations |
Diversification Drive | Explore BWXT's strategic expansion into medical and power sectors, leveraging nuclear expertise to tap new revenue streams and reduce defense dependency |
Navigating Headwinds | Delve into how BWXT addresses potential naval sector growth risks and valuation concerns while capitalizing on its monopolistic advantages in defense contracts |
Metrics to compare | BWXT | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipBWXTPeersSector | |
---|---|---|---|---|
P/E Ratio | 43.2x | 40.8x | 11.7x | |
PEG Ratio | 1.76 | −0.74 | 0.03 | |
Price/Book | 11.3x | 3.7x | 1.4x | |
Price / LTM Sales | 4.5x | 2.5x | 1.2x | |
Upside (Analyst Target) | 6.0% | 16.6% | 20.2% | |
Fair Value Upside | Unlock | −4.0% | 5.8% | Unlock |